1
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics for Hispanics/Latinos, 2012. CA Cancer J Clin.
62:283–298. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Weitz J, Koch M, Debus J, Höhler T, Galle
PR and Büchler MW: Colorectal cancer. Lancet. 365:153–165. 2005.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Lei T, Chen WQ, Zhang SW, Lei TH, Ying Q,
He ZY and Wang XH: Prevalence trend of colorectal cancer in 10
cities and counties in China from 1988 to 2002. Zhonghua zhong Liu
Za Zhi. 31:428–433. 2009.(In Chinese). PubMed/NCBI
|
5
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
6
|
Lech G, Slotwinski R and Krasnodebski IW:
The role of tumor markers and biomarkers in colorectal cancer.
Neoplasma. 61:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
7
|
Markowitz SD and Bertagnolli MM: Molecular
origins of cancer: Molecular basis of colorectal cancer. N Engl J
Med. 361:2449–2460. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Andreyev HJ, Norman AR, Cunningham D,
Oates JR and Clarke PA: Kirsten ras mutations in patients with
colorectal cancer: The multicenter ‘RASCAL’ study. J Natl Cancer
Inst. 90:675–684. 1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Andreyev HJ, Norman AR, Cunningham D,
Oates J, Dix BR, Iacopetta BJ, Young J, Walsh T, Ward R, Hawkins N,
et al: Kirsten ras mutations in patients with colorectal cancer:
The ‘RASCAL II’ study. Br J Cancer. 85:692–696. 2001. View Article : Google Scholar : PubMed/NCBI
|
10
|
Er TK, Chen CC, Bujanda L and
Herreros-Villanueva M: Clinical relevance of KRAS mutations in
codon 13: Where are we? Cancer Lett. 343:1–5. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Malapelle U, Carlomagno C, de Luca C,
Bellevicine C and Troncone G: KRAS testing in metastatic colorectal
carcinoma: Challenges, controversies, breakthroughs and beyond. J
Clin Pathol. 67:1–9. 2014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Suppiah A and Greenman J: Clinical utility
of anti-p53 auto-antibody: Systematic review and focus on
colorectal cancer. World J Gastroenterol. 19:4651–4670. 2013.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Colussi D, Brandi G, Bazzoli F and
Ricciardiello L: Molecular pathways involved in colorectal cancer:
Implications for disease behavior and prevention. Int J Mol Sci.
14:16365–16385. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Hutchison J, Cohen Z, Onyeagucha BC, Funk
J and Nelson MA: How microRNAs influence both hereditary and
inflammatory-mediated colon cancers. Cancer Genet. 206:309–316.
2013. View Article : Google Scholar : PubMed/NCBI
|
15
|
Temraz S, Mukherji D and Shamseddine A:
Potential targets for colorectal cancer prevention. Int J Mol Sci.
14:17279–17303. 2013. View Article : Google Scholar : PubMed/NCBI
|
16
|
Fearon ER: Molecular genetics of
colorectal cancer. Annu Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kelleher FC, Rao A and Maguire A:
Circadian molecular clocks and cancer. Cancer Lett. 342:9–18. 2014.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Mazzoccoli G, Vinciguerra M, Papa G and
Piepoli A: Circadian clock circuitry in colorectal cancer. World J
Gastroenterol. 20:4197–4207. 2014. View Article : Google Scholar : PubMed/NCBI
|
19
|
Hsu CC, Lee YC, Yeh SH, Chen CH, Wu CC,
Wang TY, Chen YN, Hung LY, Liu YW, Chen HK, et al: 58-kDa
microspherule protein (MSP58) is novel Brahma-related gene 1
(BRG1)-associated protein that modulates p53/p21 senescence
pathway. J Biol Chem. 287:22533–22548. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Xu CS, Zheng JY, Zhang HL, Zhao HD and
Zhang J, Wu GQ, Wu L, Wang Q, Wang WZ and Zhang J: MSP58 knockdown
inhibits the proliferation of esophageal squamous cell carcinoma in
vitro and in vivo. Asian Pac J Cancer Prev. 13:3233–3238. 2012.
View Article : Google Scholar : PubMed/NCBI
|
21
|
Hsu CC, Chen CH, Hsu TI, Hung JJ, Ko JL,
Zhang B, Lee YC, Chen HK, Chang WC and Lin DY: The 58-kda
microspherule protein (MSP58) represses human telomerase reverse
transcriptase (hTERT) gene expression and cell proliferation by
interacting with telomerase transcriptional element-interacting
factor (TEIF). Biochim Biophys Acta. 1843:565–579. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Ren Y, Busch RK, Perlaky L and Busch H:
The 58-kDa microspherule protein (MSP58), a nucleolar protein,
interacts with nucleolar protein p120. Eur J Biochem. 253:734–742.
1998. View Article : Google Scholar : PubMed/NCBI
|
23
|
Lin DY and Shih HM: Essential role of the
58-kDa microspherule protein in the modulation of Daxx-dependent
transcriptional repression as revealed by nucleolar sequestration.
J Biol Chem. 277:25446–25456. 2002. View Article : Google Scholar : PubMed/NCBI
|
24
|
Ivanova AV, Ivanov SV and Lerman ML:
Association, mutual stabilization and transcriptional activity of
the STRA13 and MSP58 proteins. Cell Mol Life Sci. 62:471–484. 2005.
View Article : Google Scholar : PubMed/NCBI
|
25
|
Shimono K, Shimono Y, Shimokata K,
Ishiguro N and Takahashi M: Microspherule protein 1, Mi-2beta and
RET finger protein associate in the nucleolus and up-regulate
ribosomal gene transcription. J Biol Chem. 280:39436–39447. 2005.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Hirohashi Y, Wang Q, Liu Q, Du X, Zhang H,
Sato N and Greene MI: p78/MCRS1 forms a complex with centrosomal
protein Nde1 and is essential for cell viability. Oncogene.
25:4937–4946. 2006. View Article : Google Scholar : PubMed/NCBI
|
27
|
Shi H, Li SJ, Zhang B, Liu HL and Chen CS:
Expression of MSP58 in human colorectal cancer and its correlation
with prognosis. Med Oncol. 29:3136–3142. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Zhong M, Zhang X, Li B, Chen CS, Ji GL, Li
SX, Bi DQ, Zhao QC and Shi H: Expression of MSP58 in hepatocellular
carcinoma. Med Oncol. 30:5392013. View Article : Google Scholar : PubMed/NCBI
|
29
|
Lin W, Zhang J, Zhang J, Liu X, Fei Z, Li
X, Davidovic L, Tang Z, Shen L, Deng Y, Yang A, et al:
RNAi-mediated inhibition of MSP58 decreases tumour growth,
migration and invasion in a human glioma cell line. J Cell Mol Med.
13:4608–4622. 2009. View Article : Google Scholar : PubMed/NCBI
|
30
|
Wu L, Zhang ZG, Qin HZ and Zhang J, Gao
GD, Lin W, Wang J and Zhang J: Downregulation of MSP58 suppresses
cell proliferation in neuroblastoma cell lines. Neuroreport.
23:932–936. 2012. View Article : Google Scholar : PubMed/NCBI
|
31
|
Lin W, Li XM, Zhang J, Huang Y, Wang J,
Zhang J, Jiang XF and Fei Z: Increased expression of the 58-kD
microspherule protein (MSP58) is correlated with poor prognosis in
glioma patients. Med Oncol. 30:6772013. View Article : Google Scholar : PubMed/NCBI
|
32
|
Liang Y, Liu M, Wang P, Ding X and Cao Y:
Analysis of 20 genes at chromosome band 12q13: RACGAP1 and MCRS1
overexpression in nonsmall-cell lung cancer. Genes Chromosomes
Cancer. 52:305–315. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Okumura K, Zhao M, DePinho RA, Furnari FB
and Cavenee WK: PTEN: a novel anti-oncogenic function independent
of phosphatase activity. Cell Cycle. 4:540–542. 2005. View Article : Google Scholar : PubMed/NCBI
|
34
|
Song H, Li Y, Chen G, Xing Z, Zhao J,
Yokoyama KK, Li T and Zhao M: Human MCRS2, a cell-cycle-dependent
protein, associates with LPTS/PinX1 and reduces the telomere
length. Biochem Biophys Res Commun. 316:1116–1123. 2004. View Article : Google Scholar : PubMed/NCBI
|
35
|
Kuo CW, Wang WH and Liu ST: Mapping
signals that are important for nuclear and nucleolar localization
in MCRS2. Mol Cells. 31:547–552. 2011. View Article : Google Scholar : PubMed/NCBI
|
36
|
Wu JL, Lin YS, Yang CC, Lin YJ, Wu SF, Lin
YT and Huang CF: MCRS2 represses the transactivation activities of
Nrf1. BMC Cell Biol. 10:92009. View Article : Google Scholar : PubMed/NCBI
|
37
|
Andersen DS, Raja SJ, Colombani J, Shaw
RL, Langton PF, Akhtar A and Tapon N: Drosophila MCRS2 associates
with RNA polymerase II complexes to regulate transcription. Mol
Cell Biol. 30:4744–4755. 2010. View Article : Google Scholar : PubMed/NCBI
|
38
|
Gold P and Freedman SO: Specific
carcinoembryonic antigens of the human digestive system. J Exp Med.
122:467–481. 1965. View Article : Google Scholar : PubMed/NCBI
|
39
|
Wiggers T, Arends JW and Volovics A:
Regression analysis of prognostic factors in colorectal cancer
after curative resections. Diseases of the colon and rectum.
31:33–41. 1988. View Article : Google Scholar : PubMed/NCBI
|
40
|
Tan E, Gouvas N, Nicholls RJ, Ziprin P,
Xynos E and Tekkis PP: Diagnostic precision of carcinoembryonic
antigen in the detection of recurrence of colorectal cancer. Surg
Oncol. 18:15–24. 2009. View Article : Google Scholar : PubMed/NCBI
|
41
|
Obrocea FL, Sajin M, Marinescu EC and
Stoica D: Colorectal cancer and the 7th revision of the TNM staging
system: Review of changes and suggestions for uniform pathologic
reporting. Romanian journal of morphology and embryology = Revue
roumaine de morphologie et embryologie. 52:537–544. 2011.PubMed/NCBI
|
42
|
Tristan C, Shahani N, Sedlak TW and Sawa
A: The diverse functions of GAPDH: views from different subcellular
compartments. Cell Signal. 23:317–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
43
|
Ji J, Zhao L, Wang X, Zhou C, Ding F, Su
L, Zhang C, Mao X, Wu M and Liu Z: Differential expression of S100
gene family in human esophageal squamous cell carcinoma. J Cancer
Res Clin Oncol. 130:480–486. 2004. View Article : Google Scholar : PubMed/NCBI
|
44
|
Zhong M, Zhang X, Li B, Chen CS, Ji GL, Li
SX, Bi DQ, Zhao QC and Shi H.: Expression of MSP58 in
hepatocellular carcinoma. Med Oncol. 30:5392013. View Article : Google Scholar : PubMed/NCBI
|